Dan Kemp

President & CEO

WUGEN Inc. is a biotechnology company developing a novel CAR-T therapy platform for fratricide-resistant CAR-T cell therapy for T-cell malignancies.

Wugen

biotechnology

dkemp@wugen.com

Middletown United States


Ayman Kabakibi
Chief Operating Officer
Wugen
Biotechnology
United States
Matthew Cooper
Chief Scientific Officer and Co-Founder
Wugen
Biotechnology
United States